Group Training for Social Skills in Psychosis (GRASP)

August 31, 2021 updated by: Dr Matteo Cella, King's College London

Exploring the Feasibility of Social Skills Training in People With Psychosis.

The purpose of this study is to assess the feasibility of a social skills training group for people with psychosis.

Study Overview

Status

Completed

Conditions

Detailed Description

This study is assessing the feasibility of a psychological intervention targeting social cognition problems in people with psychosis. The intervention is a group psychological treatment facilitated by a clinical psychologist. The group therapy takes advantage of audiovisual material and practical exercises to illustrate strategies and thinking styles that may help participants overcome difficulties in social settings.

A second objective of this study is to test a new method to measure social cognition by using portable devices. These devices will be carried by participants in their everyday life and will ask about their social activity levels at random times and record activity levels.

Study Type

Interventional

Enrollment (Actual)

48

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 65 years (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Diagnosis part of the psychosis spectrum (according to DSM-IV or DSM-V or ICD-10)
  • Good command of the English language
  • Social engagement problems as evidenced by care coordinator report and number of hours spent in social activities per week lower than 10.

Exclusion Criteria:

  • Primary diagnosis of substance abuse disorder
  • Change in antipsychotic medication in the last six weeks
  • Significant learning difficulties (premorbid IQ lower than 70)

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: GRASP
GRoup trAining for Social skills in Psychosis
GRoup trAining for Social skills in Psychosis
Active Comparator: Standard care
Treatment as usual as provided by care team
Treatment as usual

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Time Frame
Therapy drop-out rate
Time Frame: 8 weeks post randomisation
8 weeks post randomisation
Number of therapy session attended
Time Frame: 8 weeks post randomisation
8 weeks post randomisation

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Matteo Cella, DClinPsy, Institute of Psychiatry

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Helpful Links

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

March 1, 2014

Primary Completion (Actual)

December 31, 2015

Study Completion (Actual)

November 30, 2016

Study Registration Dates

First Submitted

July 2, 2014

First Submitted That Met QC Criteria

July 3, 2014

First Posted (Estimate)

July 4, 2014

Study Record Updates

Last Update Posted (Actual)

September 5, 2021

Last Update Submitted That Met QC Criteria

August 31, 2021

Last Verified

August 1, 2021

More Information

Terms related to this study

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Psychotic Disorders

Clinical Trials on GRASP

3
Subscribe